Effect of ammonia on GABA uptake and release in cultured astrocytes

Neurochemistry International

Volumn 36, Issue 4-5, 2000, Pages 389-395

  Bender, Alex S ^a   Norenberg, Michael D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA; AMMONIUM CHLORIDE;

4 AMINOBUTYRIC ACID RELEASE; 4 AMINOBUTYRIC ACID UPTAKE; ANIMAL CELL; ASTROCYTE; CONFERENCE PAPER; CONTROLLED STUDY; GABAERGIC SYSTEM; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

AMMONIA; AMMONIUM CHLORIDE; ANIMALS; ASTROCYTES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; KINETICS; RATS; TIME FACTORS;

EID: 0033982710     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00130-8     Document Type: Conference Paper

References (63)

1. Aguila-Mansilla N., Bender A.S., Norenberg M.D. Effect of ammonia, peripheral benzodiazepine ligands and neurosteroids on GABA uptake in cultured astrocytes. J. Neurochem. 70:(Suppl. 1):1998;S28.
2. Albrecht J., Bender A.S., Norenberg M.D. Ammonia stimulates the release of taurine from cultured astrocytes. Brain Res. 660:1994;288-292.
3. +-ATPase activity and GABA uptake in astroglial cell-enriched fractions and synaptosomes derived from rats in the early stage of experimental hepatogenic encephalopathy. Acta Neurol. Scand. 72:1985;317-320.
4. Basile A.S. The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy. Synapse. 7:1991;141-150.
5. Basile A.S., Jones E.A. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology. 25:1997;1303-1305.
6. Basile A.S., Jones E.A., Skolnick P. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacol. Rev. 43:1991;27-71.
7. Basile A.S., Gammal S., Mullen K., Jones E.A., Skolnick P. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J. Neurosci. 8:1988;2414-2421.
8. Basile A.S., Hughes R.D., Harrison P.M., Murata Y., Pannell L., Jones E.A., Williams R., Skolnick P. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N. Engl. J. Med. 325:1991;473-478.
9. Bassett M.L., Mullen K.D., Scholz B., Fenstermacher J.D., Jones E.A. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology. 98:1990;747-757.
10. Benjamin A.M. Ammonia. Lajtha A. Handbook of Neurochemistry. vol. 1:1982;117-137 Plenum Press, New York.
11. Booher J., Sensenbrenner M. Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology. 2:1972;97-105.
12. Bosman D.K., Deutz N.E.P., Maas M.A.W., Van Eijk H.M.H., Smit J.J.H., De Haan J.G., Chamuleau R.A.F.M. Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral cortex microdialysis. J. Neurochem. 59:1992;591-599.
13. Butterworth R.F. Pathogenesis of acute hepatic encephalopathy. Digestion. 59:(Suppl. 2):1998;16-21.
14. Conn H.O. Hepatic encephalopathy. Schiff L., Schiff E.R. Diseases of the Liver. 1993;1036-1061 Lippincott, Philadelphia.
15. Cooper A.J.L., Plum F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 67:1987;440-519.
16. Dejong C.H., Kampman M.T., Deutz N.E., Soeters P.B. Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J. Neurochem. 59:1992;1071-1079.
17. DeLorey T.M., Olsen R.W. GABA and glycine. Siegel G.J., Agranoff B.W., Albers R.W., Molinoff P.B. Basic Neurochemistry. 1994;389-399 Raven Press, New York.
18. Diaz Munoz M., Tapia R. Regional brain GABA metabolism and release during hepatic coma produced in rats chronically treated with carbon tetrachloride. Neurochem. Res. 13:1988;37-44.
19. Ducis I., Norenberg L.O.B., Norenberg M.D. The benzodiazepine receptor in cultured astrocytes from genetically epilepsy-prone rats. Brain Res. 531:1990;318-321.
20. Erecinska M., Pastuszko A., Wilson D.F., Nelson D. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J. Neurochem. 49:1987;1258-1265.
21. Ferenci P., Grimm G., Meryn S., Gangl A. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology. 96:1989;240-243.
22. Ferenci P., Jacobs R., Pappas S.C., Schafer D.F., Jones E.A. Enzymes of cerebral GABA metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: evidence for decreased cerebral GABA-transaminase activity. J. Neurochem. 42:1984;1487-1490.
23. Ferenci P., Covell D., Schafer D., Waggoner J., Shrager R., Jones E.A. Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure. Hepatology. 3:1983;507-512.
24. Gammal S.H., Basile A.S., Geller D., Skolnick P., Jones E.A. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology. 11:1990;371-378.
25. A receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res. 720:1996;35-44.
26. Hansson E., Eriksson P., Nilsson M. Amino acid and monoamine transport in primary astroglial cultures from defined brain regions. Neurochem. Res. 10:1985;1335-1341.
27. Ito M., Kikuchi S., Matsumoto H. Glucose metabolism in the rat cerebral cortex in chronic hepatic failure with reference to glucose-derived amino acids. No. To. Shinkei. 38:1986;353-357.
28. Jones E.A., Basile A.S. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure? Metab. Brain Dis. 13:1998;351-360.
29. Jones E.A., Weissenborn K. Neurology and the liver. J. Neurol. Neurosurg. Psychiatry. 63:1997;279-293.
30. Jones E.A., Yurdaydin C., Basile A.S. The GABA hypothesis - state of the art. Adv. Exp. Med. Biol. 368:1994;89-101.
31. Larsson O.M., Hertz L., Schousboe A. Uptake of GABA and nipecotic acid in astrocytes in primary cultures: changes in the sodium coupling ratio during differentiation. J. Neurosci. Res. 16:1986;699-708.
32. Larsson O.M., Drejer J., Hertz L., Schousboe A. Ion dependency of uptake and release of GABA and (RS)-nipecotic acid studied in cultured mouse brain cortex neurons. J. Neurosci. Res. 9:1983;291-302.
33. Lavoie J., Giguere J.F., Layrargues G.P., Butterworth R.F. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J. Neurochem. 49:1987;692-697.
34. Lavoie J., Desy L., Tonon M.C., Vaudry H., Pelletier G., Butterworth R.F. Octadecaneuropeptide: an endogenous ligand in hepatic encephalopathy. Ann. Endocrinol. 50:1989;35N.
35. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
36. Maddison J.E., Watson W.E., Johnston G.A. L-glutamate and gamma-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy. Metab. Brain Dis. 10:1995;135-141.
37. Maddison J.E., Dodd P.R., Johnston G.A.R., Farrell G.C. Brain γ-aminobutyric acid is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma γ-aminobutyric acid-like activity. Gastroenterology. 93:1987;1062-1068.
38. Mans A.M., Saunders S.J., Kirsch R.E., Biebuyck J.F. Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J. Neurochem. 32:1978;285-292.
39. Marino A.T., DiStefano J.J., Landau E.M. DIMSUM: an expert system for multiexponential model discrimination. Am. J. Physiol. 262:1992;E546-E556.
40. Mousseau D.D., Butterworth R.F. Current theories on the pathogenesis of hepatic encephalopathy. Proc. Soc. Exp. Biol. Med. 206:1994;329-344.
41. Mullen K.D., Szauter K.M., Kaminsky-Russ K. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet. 336:1990;81-83.
42. Mullen K.D., Martin J.V., Mendelson W.B., Bassett M.L., Jones E.A. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy. Lancet. I:1988;457-459.
43. Norenberg M.D. Astroglial dysfunction in hepatic encephalopathy. Metab. Brain Dis. 13:1998;319-335.
44. Norenberg M.D., Mozes L.W., Papendick R.E. Effect of ammonia on glutamate, GABA and rubidium uptake by astrocytes. Ann. Neurol. 18:1985;149.
45. B binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res. 629:1993;355-357.
46. Olde Damink S.W., Dejong C.H., Deutz N.E., Soeters P.B. Effects of simulated upper gastrointestinal hemorrhage on ammonia and related amino acids in blood and brain of chronic portacaval-shunted rats. Metab. Brain Dis. 12:1997;121-135.
47. Pomier-Layrargues G., Giguère J.F., Lavoie J., Perney P., Gagnon S., D'Amour M., Wells J., Butterworth R.F. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology. 19:1994;32-37.
48. Raabe W.A. Neurophysiology of ammonia intoxication. Butterworth R.F., Pomier Layrargues G. Hepatic Encephalopathy: Physiology and Treatment. 1989;49-77 Humana Press, Clifton, New Jersey.
49. Rao V.R.L., Audet R.M., Butterworth R.F. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study. J. Neurochem. 65:1995;1221-1228.
50. Rothstein J.D., McKhann G., Guarneri P., Barbaccia M.L., Guidotti A., Costa E. Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy. Ann. Neurol. 26:1989;57-62.
51. Roy S., Pomier Layrargues G., Butterworth R.F., Huet P.M. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology. 8:1988;845-849.
52. Schafer D.F., Pappas S.C., Brody L.E., Jacobs R., Jones E.A. Visual evoked potentials in a rabbit model of hepatic encephalopathy - 1: sequential changes and comparisons with drug-induced coma. Gastroenterology. 86:1984;540-545.
53. Schousboe A. Transport and metabolism of glutamate and GABA in neurons and glial cells. Int. Rev. Neurobiol. 22:1981;1-45.
54. Schousboe A., Westergaard N. Transport of neuroactive amino acids in astrocytes. Kettenmann H., Ransom B.R. Neuroglia. 1995;246-258 Oxford University Press, New York.
55. Schousboe A., Hertz L., Svenneby G. Uptake and metabolism of GABA in astrocytes cultured from dissociated mouse brain hemispheres. Neurochem. Res. 2:1977;217-229.
56. Schousboe A., Larsson O.M., Drejer J., Krogsgaard-Larsen P., Hertz L. Uptake and release processes for glutamine, glutamate and GABA in cultured neurons and astrocytes. Hertz L., Kvamme E., McGeer E.G., Schousboe A. Glutamine, Glutamate, and GABA in the Central Nervous System. 1983;297-315 Alan R Liss, New York.
57. Swain M., Butterworth R.F., Blei A.T. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology. 15:1992;449-453.
58. Swain M.S., Bergeron M., Audet R., Blei A.T., Butterworth R.F. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant liver failure. Hepatology. 16:1992;1028-1035.
59. A response in dissociated rat cortical neurons. Neurosci. Lett. 151:1993;51-54.
60. Tossman U., Eriksson S., Delin A., Hagenfeldt L., Law D., Ungerstedt U. Brain amino acids measured by intracerebral dialysis in portacaval shunted rats. J. Neurochem. 41:1983;1046-1051.
61. Watanabe A., Shiota T., Takei N., Nagashima H. Excitatory and inhibitory amino acid neurotransmitters and ammonia metabolism in hepatic failure rats. Res. Exp. Med. 185:1985;399-404.
62. Wikell C., Bergqvist P.B.F., Hjorth S., Apelqvist G., Björk H., Bengtsson F. Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy. Clin. Neuropharmacol. 21:1998;296-306.
63. Wysmyk U., Oja S.S., Saransaari P., Albrecht J. Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy. Neurochem. Res. 17:1992;1187-1190.